Differential effects of biological DMARDs on peripheral immune cell phenotypes in patients with rheumatoid arthritis
Sign Up to like & getrecommendations! Published in 2018 at "Rheumatology"
DOI: 10.1093/rheumatology/kex012
Abstract: Objective The aim of this study was to assess the therapeutic effects of biological DMARDs (bDMARDs) on the diversity of immune cell phenotypes in peripheral blood of patients with RA. Methods Peripheral immune cell phenotypes… read more here.
Keywords: cell phenotypes; immune cell; effects biological; biological dmards ... See more keywords
Precision medicine using different biological DMARDs based on characteristic phenotypes of peripheral T helper cells in psoriatic arthritis
Sign Up to like & getrecommendations! Published in 2019 at "Rheumatology"
DOI: 10.1093/rheumatology/key069
Abstract: Objectives We sought to investigate the selection of specific biological DMARDs (bDMARDs) based on characteristic lymphocyte phenotypes for treating PsA. Methods Of 64 patients with PsA resistant to MTX, 26 underwent bDMARDs therapy selected according… read more here.
Keywords: medicine; treatment; th1; biological dmards ... See more keywords
FRI0691 DISCREPANCY BETWEEN THE EFFICACY OF BIOLOGICAL DMARDS BASED ON RANDOMIZED CONTROLLED TRIALS AND THE EFFICACY OF BIOLOGICAL DMARDS IN REAL-WORLD SETTINGS IN PATIENTS WITH RHEUMATOID ARTHRITIS: A STUDY USING THE IORRA COHORT
Sign Up to like & getrecommendations! Published in 2019 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2019-eular.6589
Abstract: Background Randomized controlled trials (RCTs), which are currently considered to provide the highest level of evidence, include patients with high disease activity and exclude those with comorbidities often seen in the real world. With the… read more here.
Keywords: none; iorra cohort; efficacy biological; none declared ... See more keywords